Abstract
Systemic therapies are a crucial part of the armamentarium in the fight against cancer. Though the modern era of chemotherapy began in the 1940s with the use of estrogen to treat prostate cancer, today’s weapons include developments in cytotoxic drugs, targeted agents, and immunotherapies. Novel formulations, alternative dosing regimens, and varying schedules, sequences, combinations, and routes of administration have abounded. Fortunately, advances in supportive therapies have also evolved to help ameliorate gastrointestinal and hematologic toxicities of these treatments. A thorough understanding of the mechanisms of tumor growth, as well as therapeutic drug mechanism of action, efficacy, potential toxicity, and options for ameliorating those toxicities are essential to optimizing patient care.
| Original language | English |
|---|---|
| Title of host publication | DiSaia and Creasman Clinical Gynecologic Oncology |
| Publisher | Elsevier |
| Pages | 443-463 |
| Number of pages | 21 |
| ISBN (Electronic) | 9780323776844 |
| ISBN (Print) | 9780323776868 |
| DOIs | |
| State | Published - Jan 1 2023 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Chemotherapy
- gynecologic cancer
- hormonal therapy
- immunotherapy
- systemic therapy
Fingerprint
Dive into the research topics of 'Basic principles of chemotherapy and other systemic therapies'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver